DIMA Biotechnology
PrivateCompany Overview
DIMA Biotechnology is a biotechnology company that provides preclinical research and development solutions, specializing in membrane protein and monoclonal antibody development for the biopharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
antibody discoverybiopharmaceuticalcontract research organizationCRObispecific antibodymonoclonal antibodypreclinical drug developmentdrug discoveryantibody engineeringtherapeutic antibodyoncology therapeuticsautoimmune disease researchprotein expressionbiotech servicesdrug pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DIMA Biotechnology Comparables
Compare DIMA Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harbour BioMed | 79% | |
| Adimab | 77% | |
| Alloy Therapeutics | 76% | |
DIMA Biotechnology Funding Rounds
Historical fundraising activity
DIMA Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DIMA Biotechnology's valuation, stock price, and market status.